Form 8-K - Current report:
SEC Accession No. 0001193125-18-233611
Filing Date
2018-08-01
Accepted
2018-07-31 19:43:35
Documents
3
Period of Report
2018-07-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d596171d8k.htm 8-K 28327
2 EX-99.1 d596171dex991.htm EX-99.1 16066
3 GRAPHIC g596171ni1.jpg GRAPHIC 15440
  Complete submission text file 0001193125-18-233611.txt   67057
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 18982508
SIC: 2835 In Vitro & In Vivo Diagnostic Substances